PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
Hunan Cancer Hospital
Hunan Cancer Hospital
Sichuan University
Istituto Clinico Humanitas
Istituto Clinico Humanitas
National Cancer Institute (NCI)
National Cancer Institute (NCI)